| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 03/19/2008 | EP1900815A2 In vivo production of small interfering RNAs that mediate gene silencing |
| 03/19/2008 | EP1900753A2 Method of administering therapeutic polypeptides, and polypeptides therefor |
| 03/19/2008 | EP1900739A1 Diazolodiazine derivatives as kinase inhibitors |
| 03/19/2008 | EP1900738A2 Substituted pyrroline kinase inhibitors |
| 03/19/2008 | EP1900727A1 Aminopyridine derivatives as kinase inhibitors |
| 03/19/2008 | EP1900375A1 Calreticulin for its use as a medication for the treatment of cancer in a mammal |
| 03/19/2008 | EP1899459A2 Obtention of food- or auto-antigen specific tr1 cells from a leukocyte or pbmc population |
| 03/19/2008 | EP1899378A2 Il-1 beta binding antibodies and fragments thereof |
| 03/19/2008 | EP1899376A2 Antibodies against hmgb1 and fragments thereof |
| 03/19/2008 | EP1899367A1 Mutant allergen(s) |
| 03/19/2008 | EP1899332A1 Pyrido(3,2-d)pyrimidines and pharmaceutical compositions useful for treating hepatitis c. |
| 03/19/2008 | EP1898937A1 Heparin coating of biological tissue |
| 03/19/2008 | EP1898719A2 Nutritional formulations containing octenyl succinate anahydride-modified tapioca starch |
| 03/19/2008 | EP1562933B1 Substituted amine derivatives and methods of use in the treatment of angiogenesis related disorders |
| 03/19/2008 | EP1532130A4 Process for the production of an immunosuppressant |
| 03/19/2008 | EP1530573B1 Condensed heterocyclic pyrazole derivatives as kinase inhibitors |
| 03/19/2008 | EP1499316B1 (1-4-piperidinyl)benzimidazole derivatives useful as histamine h3 antagonists |
| 03/19/2008 | EP1432715B1 Pyrimidine derivatives |
| 03/19/2008 | EP1414453B1 Fexofenadine hydrochloride polymorph |
| 03/19/2008 | EP1307423B1 Processes for the production of fexofenadine |
| 03/19/2008 | EP1306431B1 Tumor antigen |
| 03/19/2008 | EP1303496B9 Pyrimidine derivatives |
| 03/19/2008 | EP1149091B1 4-(heterocyclylsulfonamido)-5-methoxy-6-(2-methoxyphenoxy)-2-phenyl- or pyridylpyrimidines as endothelin receptor antagonists |
| 03/19/2008 | EP1009831B1 Agonist antibodies to the thrombopoietin receptor, and their therapeutic uses |
| 03/19/2008 | CN101146825A A molecule and chimeric molecules thereof |
| 03/19/2008 | CN101146529A Novel thiophene derivatives as sphingosine-1-phosphate-1 receptor agonists |
| 03/19/2008 | CN101143898A Treatment of allergic conditions by use of IL-21 |
| 03/19/2008 | CN101143893A Thymus tripeptide active isomer and preparation method and medical use thereof |
| 03/19/2008 | CN101143885A Glucocorticoids derivative, preparation method and application thereof |
| 03/19/2008 | CN101143834A Polymorphism for N-(4-trifluoromethylphenyl)-2-cyano-3-hydroxycrotonamide sodium salt and preparation method thereof |
| 03/19/2008 | CN101143214A Important regulating gene RPS6KA2 for IL-2RG signal pathway |
| 03/19/2008 | CN101143155A Double ginseng composition and its application |
| 03/19/2008 | CN101143025A Mixed type liquid cigarette and its preparation technique and application |
| 03/19/2008 | CN100375786C Recombinant MVA capable of expressing structural HCV antigens |
| 03/19/2008 | CN100375785C Clone, expression and anti-tick immanoprotection action of falcate rhipicephalus RhcA and RhcB genes |
| 03/18/2008 | US7345151 Antagonists specific for denatured collagen and methods of using same |
| 03/18/2008 | US7345090 Galenical formulation |
| 03/18/2008 | US7345077 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4- (substituted cycloalkylmethyl) imidazol-2-ones and 4- (substituted cycloalkenylmethyl) imidazol-2-ones and related compounds |
| 03/18/2008 | US7345074 Derivatives of [6,7-dihydro-5H-imidazol[1,2-a]imidazole-3-sulfonylamino]-propionamide |
| 03/18/2008 | US7345064 5-(4-pyridyl)valeric acid N-[2-(1-adamantyl)ethyl]-N-pentylamide; Autoimmune diseases such as rheumatoid arthritis, allergy and diabetes |
| 03/18/2008 | US7345063 Amides, preparation and therapeutic use as modulators of CCR-receptor activity |
| 03/18/2008 | US7345062 Substituted acylhydroxamic acids and method of reducing TNFαlevels |
| 03/18/2008 | US7345059 Diphenylpyridine derivatives, preparation and therapeutic application thereof |
| 03/18/2008 | US7344715 Method for treating multiple myeloma |
| 03/18/2008 | CA2329128C Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces |
| 03/18/2008 | CA2320430C Recombinant mistletoe lectins |
| 03/18/2008 | CA2264739C Inhibition of nuclear transcription factor nf-kb by caffeic acid phenethyl ester (cape), derivatives of cape, capsaicin (8-methyl-n-vanillyl-6-nonenamide) and resiniferatoxin |
| 03/18/2008 | CA2219659C Rapamycin derivatives |
| 03/18/2008 | CA2166102C Redirection of cellular immunity by receptor chimeras |
| 03/18/2008 | CA2089735C Ryegrass pollen allergen |
| 03/13/2008 | WO2008030843A1 Heteroaromatic compounds having sphingosine-1-phosphate (s1p) receptor agonist and/or antagonist biological activity |
| 03/13/2008 | WO2008030119A1 Acyclic amine inhibitors of nucleoside phosphorylases and hydrolases |
| 03/13/2008 | WO2008029924A1 Cyclic aminoalkylcarboxamide derivative |
| 03/13/2008 | WO2008029908A1 Stable lyophilized pharmaceutical preparation comprising antibody |
| 03/13/2008 | WO2008029882A1 2-alkyl-6-(pyrazolopyridin-4-yl)pyridazinone derivative, addition salt thereof, and pde inhibitor comprising the derivative or the salt as active ingredient |
| 03/13/2008 | WO2008029829A1 Pyrazolopyridine derivative and phosphodiesterase (pde) inhibitor containing the same as active ingredient |
| 03/13/2008 | WO2008029825A1 Imidazole derivative |
| 03/13/2008 | WO2008029763A1 Prostaglandin fat emulsion, method for producing the same, method for stabilizing the same, and emulsifying agent |
| 03/13/2008 | WO2008029619A1 Ena antisense oligonucleotide having sequence-specific action |
| 03/13/2008 | WO2008029371A1 Pyridin-4-yl derivatives as immunomodulating agents |
| 03/13/2008 | WO2008029370A1 Pyridin-3-yl derivatives as immunomodulating agents |
| 03/13/2008 | WO2008029306A2 Thiophene derivatives as s1p1/edg1 receptor agonists |
| 03/13/2008 | WO2008028860A1 Benzotriazole kinase modulators |
| 03/13/2008 | WO2008028667A2 Use of glycolipids as adjuvants |
| 03/13/2008 | WO2008028324A1 Novel levamisole formulation for allergic rhinitis |
| 03/13/2008 | WO2008014041A3 Nutritional formulations containing octenyl succinate anahydride-modified tapioca starch |
| 03/13/2008 | WO2008011884A8 Novel immunomodulator |
| 03/13/2008 | US20080064859 Recombinant MHC molecules useful for manipulation of antigen-specific T-cells |
| 03/13/2008 | US20080064853 Nervous system protein for use in treatment and prevention of nervous system and seizure disorders |
| 03/13/2008 | US20080064753 Interleukin-1 and tumor necrosis factor-alpha modulators; syntheses of such modulators and methods of using such modulators |
| 03/13/2008 | US20080064746 Lipoxins and Aspirin-Triggered Lipoxins and Their Stable Analogs in the Treatment of Asthma and Inflammatory Airway Diseases |
| 03/13/2008 | US20080064740 Novel Thiophene Derivatives |
| 03/13/2008 | US20080064728 Heterocyclic Compounds Useful as Dpp-Iv Inhibitors |
| 03/13/2008 | US20080064722 Agent for promoting interferon-y production |
| 03/13/2008 | US20080064721 Compositions and Methods for Treating, Controlling, Reducing, Ameliorating, or Preventing Allergy |
| 03/13/2008 | US20080064720 Very Late Antigen-4 dependent inflammatory disease; asthma, allergic rhinitis, sinusitis, conjunctivitis, food allergy, inflammatory skin disorders, autoimmune disorders, or atherosclerosis, inflammatory skin disorder; methyl 3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-hydroxy-2-propenoate |
| 03/13/2008 | US20080064719 Crf Receptor Antagonists And Methods Relating Thereto |
| 03/13/2008 | US20080064715 I kappa B kinase inhibition; diabetes; (7-Chloro-1H-pyrrolo[2,3-c]pyridin-2-yl)methanol; N-Benzyl-7-chloro-1H-pyrrolo[2,3-c]pyridine-2-carboxamide |
| 03/13/2008 | US20080064713 Dry Syrup Containing Loratadine |
| 03/13/2008 | US20080064686 Programmed cell death, autoimmunity, inflammation, hyperproliferation; easy formulation, shelf life |
| 03/13/2008 | US20080064633 Preventing fibronectin deposition and fibrosis; phospholipase A2 inhibition; cystic fibrosis |
| 03/13/2008 | US20080064103 Identifying regulatory compounds which dissociate/destsbilize receptor/ligand binding activity; for use in controlled immune suppression |
| 03/13/2008 | US20080064101 Lymphoid tissue-specific cell production from hematopoietic progenitor cells in three-dimensional devices |
| 03/13/2008 | US20080064096 Isolated nucleic acid molecules which encode a soluble IL-TIF receptor or binding protein which binds to IL-TIF/IL-22, and uses thereof |
| 03/13/2008 | US20080064081 Reducing antigenicity of viral protein via amino acid sequence variation; enhancing vector transferability during gene therapy |
| 03/13/2008 | US20080063699 Method of Administering Cationic Liposomes Comprising an Active Drug |
| 03/13/2008 | US20080063660 inducing specific anti-drug antibodies using drug conjugated immunogen (bacterial toxoid) to reduce a drug's toxicity; drug is cocaine, nicotine, heroin, opium, morphine, marijuana, or antineoplastic; immunogen induces production of antibodies which sequester a subsequently administered drug; drug abuse |
| 03/13/2008 | US20080063634 genetic engineered antibody or antigen binding segment that is capable of binding to interleukins and altering the conformation structure, used for treating diseases involving immune and inflammatory responses |
| 03/13/2008 | US20080063631 prophylaxis of vascular system disorders in mammals by administering apoptotic cells and/or bodies derived from leukocytes or lymphocytes |
| 03/13/2008 | US20080063624 administering compounds which bind to the chemokine receptors, such as 1,1'-[1,4-phenylene-bis-(methylene)]-bis-1,4,8,11-tetraazacyclotetradecane, optionally with colony stimulating factors, to effect regeneration of dead myocardium |
| 03/13/2008 | CA2662998A1 Benzotriazole kinase modulators |
| 03/13/2008 | CA2662852A1 Heteroaromatic compounds having sphingosine-1-phosphate (s1p) receptor agonist and/or antagonist biological activity |
| 03/13/2008 | CA2662628A1 Acyclic amine inhibitors of nucleoside phosphorylases and hydrolases |
| 03/13/2008 | CA2662550A1 Potent immunostimulatory component in microalgae extract |
| 03/13/2008 | CA2662112A1 Imidazole derivatives and their use as cannabinoid type 2 (cb2) receptor modulators |
| 03/13/2008 | CA2661992A1 Pyrazolopyridine derivative and phosphodiesterase (pde) inhibitor containing the same as active ingredient |
| 03/13/2008 | CA2661878A1 Anti-activin a antibodies and uses thereof |
| 03/13/2008 | CA2661315A1 Pyridin-3-yl derivatives as immunomodulating agents |
| 03/13/2008 | CA2661280A1 Mucosal and systemic adjuvants comprising glycolipids,corresponding conjugates and pharmaceutical compositions. |
| 03/13/2008 | CA2661105A1 Pyridin-4-yl derivatives as immunomodulating agents |